Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. (Q51685838)

9 April 2018

title

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. (English)

1 reference

9 April 2018

acute respiratory distress syndrome

main subject

1 reference

inferred from title

author name string

Jens Christian Möller

1

1 reference

9 April 2018

Thomas Schaible

2

1 reference

9 April 2018

Claudia Roll

3

1 reference

9 April 2018

Jan-Holger Schiffmann

4

1 reference

9 April 2018

Lutz Bindl

5

1 reference

9 April 2018

Lothar Schrod

6

1 reference

9 April 2018

Irwin Reiss

7

1 reference

9 April 2018

Martina Kohl

8

1 reference

9 April 2018

Subha Demirakca

9

1 reference

9 April 2018

Roland Hentschel

10

1 reference

9 April 2018

Thomas Paul

11

1 reference

9 April 2018

Anne Vierzig

12

1 reference

9 April 2018

Peter Groneck

13

1 reference

9 April 2018

Heide von Seefeld

14

1 reference

9 April 2018

Helmut Schumacher

15

1 reference

9 April 2018

Ludwig Gortner

16

1 reference

9 April 2018

Surfactant ARDS Study Group

17

1 reference

9 April 2018

publication date

15 February 2003

1 reference

9 April 2018

published in

Intensive Care Medicine

1 reference

9 April 2018

volume

29

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

page(s)

437-446

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s00134-003-1650-1

exact match

0 references

cites work

Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Acute hypoxemic respiratory failure in children: case mix and the utility of respiratory severity indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Calf's lung surfactant extract in acute hypoxemic respiratory failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

The efficacy of inhaled nitric oxide in the treatment of acute respiratory distress syndrome. An evidence-based medicine approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

At surfactant deficiency, application of "the open lung concept" prevents protein leakage and attenuates changes in lung mechanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Surfactant treatment for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Bovine surfactant therapy for patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-003-1650-1

The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling

21 January 2018

1 reference

12 December 2020

Ventilation index and outcome in children with acute respiratory distress syndrome

1 reference

12 December 2020

Treatment of severe non-neonatal ARDS in children with surfactant and nitric oxide in a "pre-ECMO"-situation.

1 reference

12 December 2020

Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis

1 reference

12 December 2020

Short-term effect of inhaled nitric oxide and prone positioning on gas exchange in patients with severe acute respiratory distress syndrome

1 reference

12 December 2020

The significance of the initial respiratory parameters in assessing the severity of ARDS in children

1 reference

12 December 2020

Intracytoplasmic detection of cytokines in neonatal lymphocytes and monocytes by flow cytometry

1 reference

12 December 2020

Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome

1 reference

12 December 2020

Pediatric risk of mortality (PRISM) score

1 reference

12 December 2020

Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure

1 reference

12 December 2020

Predictive factors for death in paediatric acute respiratory failure

1 reference

12 December 2020

Adult respiratory distress syndrome in children

1 reference

12 December 2020

New tools in ventilatory support: high frequency ventilation, nitric oxide, tracheal gas insufflation, non-invasive ventilation.

1 reference

12 December 2020

Alveolar-arterial oxygen gradients before extracorporeal life support for severe pediatric respiratory failure: improved outcome for extracorporeal life support-managed patients?

1 reference

12 December 2020

Fluid management in ARDS: "keep them dry" or does it matter?

1 reference

12 December 2020

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group

1 reference

12 December 2020

Surfactant replacement in pediatric respiratory failure: promising therapy for the future?

1 reference

12 December 2020

Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network

1 reference

12 December 2020

Mitigation of endotoxin-induced acute lung injury in ventilated rabbits by surfactant and inhaled nitric oxide

1 reference

12 December 2020

Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient

1 reference

12 December 2020

The acute respiratory distress syndrome in children: recent UMMC experience

1 reference

12 December 2020

10.1007/S00134-003-1650-1

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

12589529

1 reference

9 April 2018